{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:40:57Z","timestamp":1788871257140,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jjcc.2014.07.016","type":"journal-article","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T09:47:11Z","timestamp":1408700831000},"page":"494-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of the effect of CYP2C19 polymorphism on clinical outcome between acute coronary syndrome and stable angina"],"prefix":"10.1016","volume":"65","author":[{"given":"Yuichiro","family":"Arima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Hokimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Mizobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Oniki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2014.07.016_bib0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0010","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0015","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0020","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2012.11.040","volume":"61","author":"Frelinger","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0025","doi-asserted-by":"crossref","first-page":"27A","DOI":"10.1016\/j.amjcard.2008.11.020","article-title":"Variability in responsiveness to oral antiplatelet therapy","volume":"103","author":"Angiolillo","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(08)61845-0","article-title":"Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study","volume":"373","author":"Collet","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2133\/dmpk.20.300","article-title":"Genetic variations and haplotypes of CYP2C19 in a Japanese population","volume":"20","author":"Fukushima-Uesaka","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2133\/dmpk.20.153","article-title":"Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies","volume":"20","author":"Furuta","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jjcc.2010.10.007","article-title":"Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy","volume":"57","author":"Yamamoto","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0060","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2011.1332","article-title":"High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI","volume":"306","author":"Parodi","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jacc.2009.12.071","article-title":"Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis","volume":"56","author":"Hulot","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0070","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0075","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1001\/jama.2011.1880","article-title":"CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis","volume":"306","author":"Holmes","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/hrt.2011.227652","article-title":"Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel","volume":"98","author":"Zabalza","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0090","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0095","first-page":"e426","volume":"123","author":"Anderson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/2.2.159","article-title":"Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes\/swabs","volume":"2","author":"Richards","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0009-9236(96)90214-3","article-title":"Genotyping of S-mephenytoin 4\u2032-hydroxylation in an extended Japanese population","volume":"60","author":"Kubota","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0110","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI200419252","article-title":"The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation","volume":"113","author":"Freson","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0049-3848(77)90199-2","article-title":"Classification of platelet aggregation patterns with two ADP solutions (the double-ADP method) and its clinical application to diabetes mellitus","volume":"11","author":"Matsuo","year":"1977","journal-title":"Thromb Res"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.thromres.2004.07.002","article-title":"The difference between clopidogrel responsiveness and posttreatment platelet reactivity","volume":"115","author":"Samara","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0125","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0130","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","article-title":"Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents","volume":"51","author":"Trenk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0135","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0140","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.2011.1703","article-title":"Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease","volume":"306","author":"Mega","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.repc.2012.02.001","article-title":"CYP2C19*2 and prognosis after an acute coronary syndrome: insights from a Portuguese center","volume":"31","author":"Teixeira","year":"2012","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0150","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1253\/circj.CJ-12-0068","article-title":"Differences in microparticle release in patients with acute coronary syndrome and stable angina","volume":"76","author":"Biasucci","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0155","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1161\/CIRCULATIONAHA.108.778837","article-title":"Hypercoagulable states in cardiovascular disease","volume":"118","author":"Chan","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0160","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1074\/jbc.R112.431916","article-title":"Cytochromes p450: roles in diseases","volume":"288","author":"Pikuleva","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2014.07.016_bib0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol Rev"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508714002214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508714002214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:54:13Z","timestamp":1760273653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508714002214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0914508714002214"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2014.07.016","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the effect of CYP2C19 polymorphism on clinical outcome between acute coronary syndrome and stable angina","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2014.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}